Loss-of-function N178T variant of the human P2Y4 receptor is associated with decreased severity of coronary artery disease and improved glucose homeostasis
Michael Horckmans, Esteban Diaz Villamil, Céline Verdier, Henrik Laurell, Jean-Bernard Ruidavets, Lucas De Roeck, Guillaume Combes, Laurent O. Martinez, Didier Communi
This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 04 December 2022.
All research outputs
#13,650,896
of 23,269,984 outputs
Outputs from Frontiers in Pharmacology
#4,138
of 16,698 outputs
Outputs of similar age
#170,296
of 439,149 outputs
Outputs of similar age from Frontiers in Pharmacology
#139
of 1,115 outputs
Altmetric has tracked 23,269,984 research outputs across all sources so far. This one is in the 41st percentile – i.e., 41% of other outputs scored the same or lower than it.
So far Altmetric has tracked 16,698 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.0. This one has gotten more attention than average, scoring higher than 74% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 439,149 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 60% of its contemporaries.
We're also able to compare this research output to 1,115 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 86% of its contemporaries.
